PT1753764E - Derivados de pirrolopiridina - Google Patents

Derivados de pirrolopiridina Download PDF

Info

Publication number: PT1753764E
Authority: PT; Portugal
Prior art keywords: pyrrolopyridine derivatives; pyrrolopyridine; derivatives
Prior art date: 2004-06-09

Application number

PT05747418T

Other languages

English (en)

Inventor

Andrew John Eatherton

Gerard Martin Paul Giblin

Matthew Russell Johnson

William Leonard Mitchell

Alcide Perboni

Brian Peter Slingsby

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-09

Filing date

2005-06-07

Publication date

2009-01-28

2004-06-09 Priority claimed from GB0412908A external-priority patent/GB0412908D0/en

2004-11-11 Priority claimed from GB0424950A external-priority patent/GB0424950D0/en

2005-06-07 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2009-01-28 Publication of PT1753764E publication Critical patent/PT1753764E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PT05747418T 2004-06-09 2005-06-07 Derivados de pirrolopiridina PT1753764E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0412908A GB0412908D0 (en)	2004-06-09	2004-06-09	Compounds
GB0424950A GB0424950D0 (en)	2004-11-11	2004-11-11	Compounds

Publications (1)

Publication Number	Publication Date
PT1753764E true PT1753764E (pt)	2009-01-28

Family

ID=34969264

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT05747418T PT1753764E (pt)	2004-06-09	2005-06-07	Derivados de pirrolopiridina

Country Status (26)

Country	Link
US (1)	US7589206B2 (pt)
EP (1)	EP1753764B1 (pt)
JP (1)	JP2008501758A (pt)
KR (1)	KR20070034049A (pt)
AR (1)	AR050158A1 (pt)
AT (1)	ATE412651T1 (pt)
AU (1)	AU2005251913A1 (pt)
BR (1)	BRPI0511874A (pt)
CA (1)	CA2569887A1 (pt)
DE (1)	DE602005010698D1 (pt)
DK (1)	DK1753764T3 (pt)
ES (1)	ES2317244T3 (pt)
HK (1)	HK1104175A1 (pt)
HR (1)	HRP20090034T3 (pt)
IL (1)	IL179603A0 (pt)
MA (1)	MA28686B1 (pt)
MX (1)	MXPA06014471A (pt)
NO (1)	NO20070067L (pt)
PE (1)	PE20060430A1 (pt)
PL (1)	PL1753764T3 (pt)
PT (1)	PT1753764E (pt)
RU (1)	RU2006147278A (pt)
SI (1)	SI1753764T1 (pt)
TW (1)	TW200611695A (pt)
UY (1)	UY28945A1 (pt)
WO (1)	WO2005121140A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4198733B2 (ja)	2003-07-22	2008-12-17	アリーナファーマシューティカルズ，インコーポレイテッド	関連性障害の予防および処置に有用な、５−ｈｔ２ａセロトニンレセプターのモジュレーターとしてのジアリールおよびアリールへテロアリールウレア誘導体
PT1753764E (pt)	2004-06-09	2009-01-28	Glaxo Group Ltd	Derivados de pirrolopiridina
EP1787991B2 (en) †	2004-07-28	2020-06-24	Takeda Pharmaceutical Company Limited	PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE
MX2007002324A (es)	2004-09-03	2007-05-11	Yuhan Corp	Derivados de pirrolo[2-3-c]piridina y procesos para la preparacion de los mismos.
US20080221097A1 (en) *	2005-08-09	2008-09-11	Glaxo Group Limited	Imidazopyridine Derivatives as Cannabinoid Receptor Ligands
GB0516379D0 (en) *	2005-08-09	2005-09-14	Glaxo Group Ltd	Compounds
US20090275611A1 (en) *	2006-04-07	2009-11-05	Boehringer Ingelheim International Gmbh	Compounds Which Modulate The CB2 Receptor
WO2008113818A1 (en) *	2007-03-21	2008-09-25	Glaxo Group Limited	Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome
GB0705803D0 (en) *	2007-03-28	2007-05-02	Glaxo Group Ltd	Novel compounds
EP2254564A1 (en)	2007-12-12	2010-12-01	Glaxo Group Limited	Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
WO2009123714A2 (en)	2008-04-02	2009-10-08	Arena Pharmaceuticals, Inc.	Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en)	2008-10-28	2010-06-03	Arena Pharmaceuticals, Inc.	Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
WO2010113834A1 (ja)	2009-03-30	2010-10-07	アステラス製薬株式会社	ピリミジン化合物
TW201200518A (en) *	2010-03-10	2012-01-01	Kalypsys Inc	Heterocyclic inhibitors of histamine receptors for the treatment of disease
UA109550C2 (uk) *	2010-07-29	2015-09-10		Конденсовані циклічні сполуки піридину
US20150051299A1 (en) *	2012-03-19	2015-02-19	Ariel-University Research And Development Company, Ltd.	Treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists
UY35630A (es)	2013-06-26	2015-01-30	Abbvie Inc	Carboxamidas primarias como inhibidores de btk
EP3307260A4 (en)	2015-06-12	2019-02-13	Axovant Sciences GmbH	DIARYL AND ARYLHETEROARYL UREA DERIVATIVES FOR PROPHYLAXIS AND TREATMENT OF SLEEP BEHAVIORAL DISORDERS IN THE REM PHASE
US10034859B2 (en)	2015-07-15	2018-07-31	Axovant Sciences Gmbh	Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
AU2019389025A1 (en) *	2018-11-30	2021-06-17	Takeda Pharmaceutical Company Limited	TYK2 inhibitors and uses thereof
US11891394B1 (en)	2023-09-06	2024-02-06	King Faisal University	Pyrrolo[2,3-c][1,6]naphthyridine-8-carboxylic acid compounds as CK2 inhibitors
US11858935B1 (en)	2023-09-06	2024-01-02	King Faisal University	Pyrrolo[2,3-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0113245B1 (en) *	1982-12-29	1989-03-15	Kureha Kagaku Kogyo Kabushiki Kaisha	Cephalosporin derivatives
CA2031927A1 (en)	1989-12-27	1991-06-28	Imperial Oil Limited	Method for improving the activity maintenance of a plasma initiator
WO1991009598A1 (en)	1990-01-05	1991-07-11	Pfizer Inc.	Azaoxindole derivatives
US5112820A (en)	1990-03-05	1992-05-12	Sterling Drug Inc.	Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
GB9109246D0 (en)	1991-04-30	1991-06-19	Ici Plc	Nitrogen derivatives
DE4129603A1 (de)	1991-09-06	1993-03-11	Thomae Gmbh Dr K	Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
TW263504B (pt)	1991-10-03	1995-11-21	Pfizer
FR2692575B1 (fr)	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5468757A (en)	1994-01-31	1995-11-21	Eli Lilly And Company	6-azaindole thromboxane synthase inhibitors
DE69502587T2 (de)	1994-02-18	1998-11-26	Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Conn.	2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e] [1,4]diazepine und ihre verwendung zur vorbeugung und behandlung von hiv-infektion
GB9420521D0 (en)	1994-10-12	1994-11-30	Smithkline Beecham Plc	Novel compounds
US5589482A (en)	1994-12-14	1996-12-31	Pfizer Inc.	Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
JPH0920779A (ja)	1995-05-01	1997-01-21	Japan Tobacco Inc	縮合ヘテロ５員環アゼピン化合物類及びその医薬用途
GB9610811D0 (en)	1996-05-23	1996-07-31	Pharmacia Spa	Combinatorial solid phase synthesis of a library of indole derivatives
US6696448B2 (en)	1996-06-05	2004-02-24	Sugen, Inc.	3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
AU4054197A (en)	1996-08-14	1998-03-06	Warner-Lambert Company	2-phenyl benzimidazole derivatives as mcp-1 antagonists
TWI242011B (en)	1997-03-31	2005-10-21	Eisai Co Ltd	1,4-substituted cyclic amine derivatives
CA2289102A1 (en)	1997-05-07	1998-11-12	Sugen, Inc.	2-indolinone derivatives as modulators of protein kinase activity
ATE237023T1 (de)	1998-01-23	2003-04-15	Voith Paper Patent Gmbh	Verfahren zur entfernung von feinen verunreinigungen aus einer faserstoffsuspension
US6232320B1 (en)	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
EP1117397A1 (en)	1998-08-31	2001-07-25	Sugen, Inc.	Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
GB9904995D0 (en)	1999-03-04	1999-04-28	Glaxo Group Ltd	Substituted aza-oxindole derivatives
WO2000053185A1 (en)	1999-03-10	2000-09-14	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
AU3396000A (en)	1999-03-10	2000-09-28	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
CA2367121A1 (en)	1999-03-10	2000-09-14	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
CA2366615A1 (en)	1999-03-10	2000-09-14	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
JP2002538204A (ja)	1999-03-10	2002-11-12	メルクエンドカムパニーインコーポレーテッド	性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
JP2003526618A (ja)	1999-03-10	2003-09-09	メルクエンドカムパニーインコーポレーテッド	性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
EP1181296A1 (en)	1999-06-03	2002-02-27	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
BR9916746A (pt)	1999-06-03	2005-01-11	Abbott Lab	Compostos anti-inflamatórios que inibem adesão de célula
AU2001234958A1 (en)	2000-02-11	2001-08-20	Bristol-Myers Squibb Company	Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
US20020061892A1 (en)	2000-02-22	2002-05-23	Tao Wang	Antiviral azaindole derivatives
EP1132389A1 (en)	2000-03-06	2001-09-12	Vernalis Research Limited	New aza-indolyl derivatives for the treatment of obesity
CA2407594A1 (en)	2000-04-28	2001-11-08	Acadia Pharmaceuticals, Inc.	Muscarinic agonists
MXPA02010627A (es)	2000-04-28	2004-05-17	Baxter Healthcare Sa	Derivados de 2-acil-indol y su uso como farmaco antitumoral.
US7332494B2 (en)	2000-08-14	2008-02-19	Janssen Pharmaceutica, N.V.	Method for treating allergies using substituted pyrazoles
JP4911864B2 (ja)	2000-08-14	2012-04-04	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	置換ピラゾール
US7342016B2 (en)	2000-08-30	2008-03-11	Schering Corporation	Farnesyl protein transferase inhibitors as antitumor agents
PT1315492E (pt)	2000-09-06	2008-10-01	Ortho Mcneil Pharm Inc	Utilização de pirazoles substituídos para o tratamento de alergias
EP1315741A2 (en)	2000-09-06	2003-06-04	Ortho-McNeil Pharmaceutical, Inc.	A method for treating allergies
JP2004510762A (ja)	2000-10-02	2004-04-08	メルク　エンド　カムパニー　インコーポレーテッド	プレニル−蛋白質トランスフェラーゼの阻害剤
IL156776A0 (en)	2001-01-17	2004-02-08	Amura Therapeutics Ltd	Inhibitors of cruzipain and other cysteine proteases
IL157029A0 (en)	2001-02-02	2004-02-08	Bristol Myers Squibb Co	Azaindoleoxoacetic piperazine derivatives and pharmaceutical compositions containing the same
US20030207910A1 (en)	2001-02-02	2003-11-06	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
WO2002072549A1 (en)	2001-03-12	2002-09-19	Millennium Pharmaceuticals, Inc.	Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
ES2278016T3 (es)	2001-04-09	2007-08-01	Novartis Vaccines And Diagnostics, Inc.	Compuestos guanidino como agonistas del receptor de melanocortina 4 (mc4-r).
SK13752003A3 (en)	2001-05-14	2004-11-03	Bristol Myers Squibb Pharma Co	Substituted pyrazinones, pyridines and pyrimidines as ligands of factor releasing corticotropine
AR035543A1 (es)	2001-06-26	2004-06-16	Japan Tobacco Inc	Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
WO2003009852A1 (en)	2001-07-24	2003-02-06	Merck & Co., Inc.	Tyrosine kinase inhibitors
DE10143079A1 (de)	2001-09-03	2003-05-15	Zentaris Ag	Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel
AU2002336462A1 (en)	2001-09-06	2003-03-24	Millennium Pharmaceuticals, Inc.	Piperazine and homopiperazine compounds
EP1438310B1 (en)	2001-10-19	2006-12-20	TransTech Pharma Inc.	Beta-carbolin derivatives as ptp-inhibitors
DE10152306A1 (de)	2001-10-26	2003-07-24	Asta Medica Ag	2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
TW200301251A (en)	2001-12-20	2003-07-01	Wyeth Corp	Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
US20030236277A1 (en)	2002-02-14	2003-12-25	Kadow John F.	Indole, azaindole and related heterocyclic pyrrolidine derivatives
AU2003226724A1 (en)	2002-03-27	2003-10-08	Glaxo Group Limited	Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
EP1495016A2 (en)	2002-04-09	2005-01-12	Astex Technology Limited	Heterocyclic compounds and their use as modulators of p38 map kinase
US20040063744A1 (en)	2002-05-28	2004-04-01	Tao Wang	Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
UA78999C2 (en)	2002-06-04	2007-05-10	Wyeth Corp	1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
US6900206B2 (en)	2002-06-20	2005-05-31	Bristol-Myers Squibb Company	Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
TW200403243A (en)	2002-07-18	2004-03-01	Wyeth Corp	1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
BR0313078A (pt)	2002-08-06	2005-07-12	Astrazeneca Ab	Composto ou um sal deste farmaceuticamente aceitável, composição farmacêutica, e, uso do composto ou de um sal deste farmaceuticamente aceitável
EP1534687B1 (en)	2002-08-21	2006-09-27	Glaxo Group Limited	2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators
GB0222493D0 (en)	2002-09-27	2002-11-06	Glaxo Group Ltd	Compounds
CA2499253A1 (en)	2002-09-30	2004-04-08	Genelabs Technologies, Inc.	Nucleoside derivatives for treating hepatitis c virus infection
FR2845388B1 (fr)	2002-10-08	2004-11-12	Sanofi Synthelabo	Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
EP1592690A1 (en)	2003-02-14	2005-11-09	Wyeth	Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
US20040214856A1 (en)	2003-04-23	2004-10-28	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
PT1753764E (pt)	2004-06-09	2009-01-28	Glaxo Group Ltd	Derivados de pirrolopiridina

2005
- 2005-06-07 PT PT05747418T patent/PT1753764E/pt unknown
- 2005-06-07 SI SI200530497T patent/SI1753764T1/sl unknown
- 2005-06-07 MX MXPA06014471A patent/MXPA06014471A/es unknown
- 2005-06-07 DE DE602005010698T patent/DE602005010698D1/de active Active
- 2005-06-07 ES ES05747418T patent/ES2317244T3/es active Active
- 2005-06-07 BR BRPI0511874-3A patent/BRPI0511874A/pt not_active IP Right Cessation
- 2005-06-07 US US11/570,099 patent/US7589206B2/en not_active Expired - Fee Related
- 2005-06-07 DK DK05747418T patent/DK1753764T3/da active
- 2005-06-07 AU AU2005251913A patent/AU2005251913A1/en not_active Abandoned
- 2005-06-07 UY UY28945A patent/UY28945A1/es unknown
- 2005-06-07 KR KR1020077000449A patent/KR20070034049A/ko not_active Application Discontinuation
- 2005-06-07 EP EP05747418A patent/EP1753764B1/en active Active
- 2005-06-07 RU RU2006147278/04A patent/RU2006147278A/ru not_active Application Discontinuation
- 2005-06-07 JP JP2007526300A patent/JP2008501758A/ja not_active Withdrawn
- 2005-06-07 AR ARP050102327A patent/AR050158A1/es unknown
- 2005-06-07 PE PE2005000651A patent/PE20060430A1/es not_active Application Discontinuation
- 2005-06-07 PL PL05747418T patent/PL1753764T3/pl unknown
- 2005-06-07 CA CA002569887A patent/CA2569887A1/en not_active Abandoned
- 2005-06-07 AT AT05747418T patent/ATE412651T1/de not_active IP Right Cessation
- 2005-06-07 WO PCT/EP2005/006182 patent/WO2005121140A1/en active Application Filing
- 2005-06-07 TW TW094118669A patent/TW200611695A/zh unknown
2006
- 2006-11-27 IL IL179603A patent/IL179603A0/en unknown
- 2006-12-28 MA MA29569A patent/MA28686B1/fr unknown
2007
- 2007-01-04 NO NO20070067A patent/NO20070067L/no not_active Application Discontinuation
- 2007-08-16 HK HK07108940.7A patent/HK1104175A1/xx not_active IP Right Cessation
2009
- 2009-01-20 HR HR20090034T patent/HRP20090034T3/xx unknown

Also Published As

Publication number	Publication date
JP2008501758A (ja)	2008-01-24
DE602005010698D1 (de)	2008-12-11
SI1753764T1 (sl)	2009-02-28
US20070219229A1 (en)	2007-09-20
ATE412651T1 (de)	2008-11-15
TW200611695A (en)	2006-04-16
ES2317244T3 (es)	2009-04-16
EP1753764B1 (en)	2008-10-29
MA28686B1 (fr)	2007-06-01
CA2569887A1 (en)	2005-12-22
WO2005121140A1 (en)	2005-12-22
IL179603A0 (en)	2007-05-15
AR050158A1 (es)	2006-10-04
PL1753764T3 (pl)	2009-04-30
EP1753764A1 (en)	2007-02-21
US7589206B2 (en)	2009-09-15
MXPA06014471A (es)	2007-03-21
KR20070034049A (ko)	2007-03-27
NO20070067L (no)	2007-02-09
BRPI0511874A (pt)	2008-01-15
UY28945A1 (es)	2006-01-31
DK1753764T3 (da)	2009-02-16
PE20060430A1 (es)	2006-05-25
RU2006147278A (ru)	2008-07-20
AU2005251913A1 (en)	2005-12-22
HRP20090034T3 (en)	2009-03-31
HK1104175A1 (en)	2008-01-04

Publication	Publication Date	Title
HK1104175A1 (en)	2008-01-04	Pyrrolopyridine derivatives
IL180481A0 (en)	2007-06-03	Aryl-pyridine derivatives
IL177968A0 (en)	2006-12-31	Tetrahydropyridoindole derivatives
HK1105971A1 (en)	2008-02-29	Pyrrazolo-pyrimidine derivatives
IL180331A0 (en)	2007-07-04	3-carbamoyl - 2 - pyridone derivative
IL179484A0 (en)	2007-05-15	New 4-benzylidene-piperidin derivatives
IL183140A0 (en)	2007-09-20	Substituted benzoquinolizine derivatives
IL182585A0 (en)	2007-07-24	Imidazo-benzodiazepine derivatives
EP1748048A4 (en)	2010-05-26	IMIDAZOPYRIDINE COMPOUND
IL183142A0 (en)	2007-09-20	New pyridothienopyrimidine derivatives
HK1100002A1 (en)	2007-08-31	4-phenyl-pyrimidine-2-carbonitrile derivatives
IL183141A0 (en)	2007-09-20	New pyridothienopyrimidine derivatives
HK1100775A1 (en)	2007-09-28	4-Amino-5-cyanopyrimidine derivatives
GB0414272D0 (en)	2004-07-28	OsK1 derivatives
IL178774A0 (en)	2007-02-11	Imidazopyridine compound
IL182001A0 (en)	2007-07-04	2-acylaminothiazole derivatives
ZA200609864B (en)	2008-08-27	Pyrrolopyridine derivatives
GB0422398D0 (en)	2004-11-10	Pyridopyrimidine derivatives
GB0422397D0 (en)	2004-11-10	3-Cyano-Quinoline derivatives
GB0405905D0 (en)	2004-04-21	Azaquinazoline derivatives